Back
Robinhood Markets, Inc. Vs. Apellis Pharmaceuticals, Inc. Industry Stock Comparison
Buy
60
HOOD
Robinhood Markets, Inc.
Last Price:
$118.14
Seasonality Move:
10.34%
Buy
54
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.96
Seasonality Move:
7.92%
Buy
60
Robinhood Markets, Inc. (HOOD)
is a Buy
Is Robinhood Markets, Inc. a Buy, Sell or Hold?
-
The current Robinhood Markets, Inc. [HOOD] share price is $118.13. The Score for HOOD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
HOOD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.97. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HOOD Stock Price Chart
What is Robinhood Markets, Inc.'s stock price today?
-
The Robinhood Markets, Inc. share price today is $118.13Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HOOD is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.97The current trend is moderately bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
HOOD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.32 | Sell |
| Relative Strength Index (14 RSI): | 44.14 | Sell |
| Chaikin Money Flow: | -9612311 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (114.41 - 131.47) | Sell |
| Bollinger Bands (100): | (110.95 - 137.69) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 59.43 | Buy |
| Chaikin Money Flow: | 440445 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.15 - 25.17) | Buy |
| Bollinger Bands (100): | (21.35 - 27.11) | Buy |
HOOD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 119.36 | Sell |
| 20-day SMA: | 125.06 | Sell |
| 50-day SMA: | 128.05 | Sell |
| 200-day SMA: | 95.91 | Buy |
| 8-day EMA: | 120.33 | Sell |
| 20-day EMA: | 122.68 | Sell |
| 50-day EMA: | 124.81 | Sell |
| 200-day EMA: | 101.15 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25 | Sell |
| 20-day SMA: | 23.86 | Buy |
| 50-day SMA: | 23.16 | Buy |
| 200-day SMA: | 21.9 | Buy |
| 8-day EMA: | 24.86 | Buy |
| 20-day EMA: | 24.03 | Buy |
| 50-day EMA: | 23.4 | Buy |
| 200-day EMA: | 24.31 | Buy |
Robinhood Markets, Inc. Earnings Growth & HOOD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.01 per share, and an increase next year of $0.32 per share.
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.44 per share.
Robinhood Markets, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||